US Private equity firm General Atlantic's $498.31 million investment for a 0.84% stake in the retail arm of India’s Reliance Industries boosted the latter's shares by as much as one percent to $30.83.
Reliance, which is diversifying from its oil-and-gas business, is perceived as a formidable rival to Amazon.com Inc and Walmart Inc’s Flipkart in India.
General Atlantic's investment gives Reliance Retail a pre-money valuation of $58.17 billion.
Reliance also operates around 12,000 brick-and-mortar stores on top of the online grocery service it launched in May.
Reliance Chairman Mukesh Ambani said their company would leverage General Atlantic’s extensive expertise in technology and consumer businesses to expand its online commerce venture.
Reliance Retail would tie neighborhood stores for online deliveries of groceries, electronics, and apparel.
With General Atlantic's investments, Reliance has now raised around $2.3 billion for its retail arm.
General Atlantic also invested in Reliance's digital business Jio platforms.


TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



